Dare Bioscience, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Dare Bioscience, Inc. has filed 759 SEC EDGAR filings since 29 May 2007

SEC filing history

Showing 651-675 of 756 matching filings.

Per page
25
Current page
27
DEFA14A File 001-36395

DEFA14A

Filing date
05 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36395

DEF14A

Filing date
05 May 2015
Reporting date
26 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Apr 2015
Reporting date
07 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-202917

FORM 424(B)4

Filing date
07 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-202917

FWP

Filing date
07 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-202917

EFFECT filing

Filing date
06 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-202917

AMENDMENT NO. 2 TO FORM S-1

Filing date
06 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-202917

AMENDMENT NO. 1 TO FORM S-1

Filing date
30 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Mar 2015
Reporting date
23 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36395

FORM 8-K

Filing date
20 Mar 2015
Reporting date
20 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36395

8-K

Filing date
19 Mar 2015
Reporting date
19 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36395

FORM 8-K

Filing date
04 Mar 2015
Reporting date
03 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88094

CERULEAN PHARMA INC. SCHEDULE 13G

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88094

SC 13G

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88094

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Feb 2015
Reporting date
05 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Feb 2015
Reporting date
05 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Feb 2015
Reporting date
05 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36395

8-K

Filing date
08 Jan 2015
Reporting date
08 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36395

8-K

Filing date
13 Nov 2014
Reporting date
13 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Oct 2014
Reporting date
29 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .